Clover Biopharmaceuticals
Focus: Clover Biopharmaceuticals is a China-based biologics company founded in 2023, focused on vaccine and immunology programs spanning COVID-19, RSV, and oncology indications. The company operates from Changxing with an early-stage pipeline concentrated in Phase 1-3 clinical development.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Clover Biopharmaceuticals
AI assessmentNot HiringNo open roles listed right now. Follow Clover Biopharmaceuticals to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthStrong
Pipeline
Late-stage
4 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
SCB-2019
COVID-19Clinical Trials (1)
NCT04405908SCB-2019 as COVID-19 Vaccine
Phase 1Help build intelligence for Clover Biopharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.